share_log

Alaunos Therapeutics | 10-K/A: Annual report (Amendment)

SEC ·  Apr 30, 2020 04:47
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.